Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04501705Recruiting
Apatinib for adults with recurring atypical or malignant meningioma
This trial tests whether apatinib can shrink or control recurring atypical/malignant meningioma that has come back after surgery and radiation. It focuses on adults with measurable regrowth on MRI and good overall health to safely take an oral medicine.
Beijing, Beijing MunicipalityAges 18–70 - NCT05286619RecruitingPhase 2
Pembrolizumab with chemotherapy for recurrent head and neck cancer
This trial studies whether pembrolizumab plus chemotherapy (platinum and gemcitabine) can control recurrent or metastatic head and neck squamous cell carcinoma that can’t be cured with local treatments. It may help shrink tumors and slow disease growth in people who haven’t had cancer medicines for this stage before.
Kuala LumpurAges 18 years+ - NCT05487391RecruitingPhase 3
QL1706 plus chemo after lung cancer surgery
This trial studies whether a study drug called QL1706 added to standard platinum chemotherapy can lower the chance of lung cancer coming back after surgery. It targets people with stage II to IIIB non-small cell lung cancer who have had their tumor fully removed.
ShanghaiAges 18 years+ - NCT05845255Recruiting
Test wearable monitoring for epilepsy quality of life and safety
This study tests a wearable device that records seizure-related information to understand how epilepsy affects daily life and safety. It may help your care team better track seizures in real-world settings and understand quality-of-life changes.
KorkAges 12–65 - NCT06352463Recruiting
Social anxiety treatment for child and parent together
This study tests a therapy for social anxiety that involves both the child and a parent. It aims to help children and teens who struggle with social anxiety by working together with their parent in treatment sessions.
Delft, South HollandAges 8–16 - NCT05931718Recruiting
Track diagnosis and treatment in autoimmune blood count disorders
This study follows adults with autoimmune blood problems like autoimmune hemolytic anemia, immune thrombocytopenia, and autoimmune/neutropenia to see how diagnosis and care work over time. You may be asked to complete follow-up visits for up to 3 years.
MilanAges 18 years+ - NCT06145711Recruiting
Stem cell therapy for Parkinson's disease
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
Shanghai, Shanghai MunicipalityAges 30–70 - NCT06601179Recruiting
HIFU ultrasound for enlarged prostate
This trial tests a focused ultrasound treatment for benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. It aims to see if HIFU can safely relieve symptoms like weak urine flow and frequent urination.
BesançonAges 50–85 - NCT06609304RecruitingPhase 4
CAR T-cell therapy after first treatment for high-risk lymphoma
This trial tests whether a type of immunotherapy called axicabtagene ciloleucel (a CAR T-cell therapy) can improve outcomes when given right after initial treatment for high-risk large B-cell lymphoma. It is for people who have not yet started treatment.
Zhengzhou, HenanAges 18–70 - NCT06634498Recruiting
Brain stimulation for internet gaming disorder
This study tests whether a non-invasive brain stimulation technique (rTMS) can help people with internet gaming disorder reduce their gaming urges and improve control. You would receive either real or sham rTMS over several sessions.
Zhenjiang, JiangsuAges 18–30 - NCT07710521Enrolling by invitation
Comparing two treatments for moral injury in veterans
This study tests two talking treatments for veterans who feel guilt, shame, or distress from events during wartime. The goal is to see which treatment helps reduce these feelings and improve daily life.
Aurora, ColoradoAges 18–89 - NCT07708727RecruitingPhase 2/Phase 3
Injectable HIV treatment vs daily pill for new patients
This trial tests a new injectable HIV treatment (GS-3242 plus lenacapavir) compared to the daily pill Biktarvy for people just starting HIV therapy. If you qualify, you would receive shots every few weeks instead of taking a daily pill.
Torrance, CaliforniaAges 18 years+ - NCT07713901Enrolling by invitation
Study of medication risk for rare thyroid cancer
This study looks at medical records to see if certain medications might be linked to a rare thyroid cancer (medullary thyroid carcinoma). You don't need to do anything new—just your existing health data will be reviewed.
Parsippany, New JerseyAges 18 years+ - NCT07711223RecruitingPhase 1/Phase 2
New HIV pill compared to standard treatment for untreated adults
This trial compares a new HIV medication (ACC017) to an existing one (dolutegravir) in adults who have HIV but have never taken HIV drugs before. The goal is to see if the new pill works as well and is safe.
BeijingAges 18 years+ - NCT07712913RecruitingPhase 3
Pregabalin for nerve pain from diabetes or shingles
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
Salvador, Estado de BahiaAges 18–75 - NCT07710443Recruiting
Mosaic Filler Trial for Midface Volume Loss
This trial tests a new cheek filler called Mosaic for people with moderate to severe cheek volume loss. It helps doctors see if Mosaic is safe and effective for filling out the midface area.
Bradenton, FloridaAges 22 years+ - NCT07713498Enrolling by invitation
Lowering inhaled steroids for tezepelumab-treated asthma patients
This trial looks at whether people with severe asthma who are taking the biologic tezepelumab can safely reduce their use of inhaled corticosteroids (ICS). It aims to see if reducing or stopping ICS affects asthma symptoms or flare-ups.
Rotterdam, South HollandAges 18 years+ - NCT07706478Recruiting
Ketamine and Talk Therapy for Tough Depression
This trial tests whether a combination of ketamine (given through an IV) and talk therapy can help people with depression that hasn't responded to other treatments. If you have tried multiple antidepressants and therapy without success, this study may offer a new option.
Doorn, UtrechtAges 18–70 - NCT07713251Recruiting
Computer skills training for teens seeking alcohol help
This study tests a computer-based program called Path180 to help teenagers ages 13-19 reduce their alcohol use. If you are already seeing a counselor or in treatment for alcohol or mental health, this program might add extra support.
Providence, Rhode IslandAges 13–19 - NCT07711171RecruitingPhase 4
Canagliflozin for type 2 diabetes with mild memory problems
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
Shanghai, Shanghai MunicipalityAges 40–75 - NCT07710300Recruiting
Training program on Section 504 for students and caregivers
This study tests a training program that helps students and their caregivers understand Section 504 of the Rehabilitation Act, which provides school supports for students with disabilities or health conditions. It may help participants learn how to use these supports effectively.
Nashville, TennesseeAges 12 years+ - NCT07708987RecruitingPhase 2
Withaferin-A for steroid-resistant graft-versus-host disease
This trial tests a plant-based medicine, Withaferin-A, in people whose graft-versus-host disease (GVHD) after a stem cell transplant has not responded to steroid treatment. GVHD is a condition where donated immune cells attack the body; this study aims to see if Withaferin-A can help control it.
Navi Mumbai, MaharashtraAges 12–65 - NCT07713550Recruiting
Genetic profiling to guide treatment for advanced solid tumors
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
AnderlechtAges 18 years+ - NCT07707063RecruitingPhase 4
Gum disease treatment with I-PRF, iodine, or laser in smokers and non-smokers
This trial tests whether adding I-PRF (a concentrate from your own blood), povidone-iodine, or laser treatment to standard deep-cleaning helps smokers and non-smokers with gum disease. You may qualify if you have moderate to severe gum disease with at least one bleeding pocket in each area of your mouth.
Tunis, Mont FleuryAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.